@article{article, title  = {{Standard- versus intermediate-dose enoxaparin for anti-factor Xa guided thromboprophylaxis in critically ill patients with COVID-19}},

 publisher = {{Springer Science and Business Media LLC}},

 url = {{http://dx.doi.org/10.1186/s12959-021-00337-z }},

 year = {{2021}},

 month = {{11}},

 author = {{Hamilton DO and Main-Ian A and Tebbutt J and Thrasher M and Waite A and Welters I}},

 doi = {{10.1186/s12959-021-00337-z}},

 volume = {{19}},

 journal = {{Thrombosis Journal}},

 issue = {{1}},

 note = {{Accessed on 2024/12/26}}}